Document and Entity Information (USD $)
|
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2012
|
Mar. 27, 2013
|
Jun. 30, 2012
|
|
Document Information [Line Items] | |||
Document Type | 10-K | ||
Amendment Flag | false | ||
Document Period End Date | Dec. 31, 2012 | ||
Document Fiscal Year Focus | 2012 | ||
Document Fiscal Period Focus | FY | ||
Trading Symbol | GALT | ||
Entity Registrant Name | GALECTIN THERAPEUTICS INC | ||
Entity Central Index Key | 0001133416 | ||
Current Fiscal Year End Date | --12-31 | ||
Entity Well-known Seasoned Issuer | No | ||
Entity Current Reporting Status | Yes | ||
Entity Voluntary Filers | No | ||
Entity Filer Category | Smaller Reporting Company | ||
Entity Common Stock, Shares Outstanding | 16,109,090 | ||
Entity Public Float | $ 29,900,000 |
X | ||||||||||
- Definition
If the value is true, then the document is an amendment to previously-filed/accepted document. No definition available.
|
X | ||||||||||
- Definition
End date of current fiscal year in the format --MM-DD. No definition available.
|
X | ||||||||||
- Definition
This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY. No definition available.
|
X | ||||||||||
- Definition
This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Definition
The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD. No definition available.
|
X | ||||||||||
- Definition
The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other". No definition available.
|
X | ||||||||||
- Definition
A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument. No definition available.
|
X | ||||||||||
- Definition
Indicate "Yes" or "No" whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure. No definition available.
|
X | ||||||||||
- Definition
Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure. No definition available.
|
X | ||||||||||
- Definition
State aggregate market value of voting and non-voting common equity held by non-affiliates computed by reference to price at which the common equity was last sold, or average bid and asked price of such common equity, as of the last business day of registrant's most recently completed second fiscal quarter. The public float should be reported on the cover page of the registrants form 10K. No definition available.
|
X | ||||||||||
- Definition
The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Indicate "Yes" or "No" if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. No definition available.
|
X | ||||||||||
- Definition
Indicate "Yes" or "No" if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A. No definition available.
|
X | ||||||||||
- Definition
Trading symbol of an instrument as listed on an exchange. No definition available.
|
X | ||||||||||
- Definition
Undesignated Capital Stock, Value No definition available.
|
X | ||||||||||
- Definition
Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Definition
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The carrying amount of consideration received or receivable as of the balance sheet date on potential earnings that were not recognized as revenue in conformity with GAAP, and which are expected to be recognized as such within one year or the normal operating cycle, if longer, including sales, license fees, and royalties, but excluding interest income. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Cumulative net losses reported during the development stage. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Total of all Liabilities and Stockholders' Equity items (or Partners' Capital, as applicable), including the portion of equity attributable to noncontrolling interests, if any. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Definition
Aggregate carrying amount, as of the balance sheet date, of noncurrent obligations not separately disclosed in the balance sheet. Noncurrent liabilities are expected to be paid after one year (or the normal operating cycle, if longer). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The total of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer, and the aggregate carrying amount of current assets, as of the balance sheet date, not separately presented elsewhere in the balance sheet. Current assets are expected to be realized or consumed within one year (or the normal operating cycle, if longer). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Amount, net of accumulated depreciation, depletion and amortization, of long-lived physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Cash and equivalents whose use in whole or in part is restricted for the long-term, generally by contractual agreements or regulatory requirements. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Definition
Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer. No definition available.
|
X | ||||||||||
- Definition
Undesignated Capital Stock, No Par Value No definition available.
|
X | ||||||||||
- Definition
Undesignated Capital Stock, Shares Authorized No definition available.
|
X | ||||||||||
- Definition
Undesignated Capital Stock, Shares, Outstanding No definition available.
|
X | ||||||||||
- Definition
Face amount or stated value of common stock per share; generally not indicative of the fair market value per share. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The maximum number of common shares permitted to be issued by an entity's charter and bylaws. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The aggregate liquidation preference (or restrictions) of stock classified as temporary equity that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The aggregate amount to be paid by the entity upon redemption of the security that is classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
Consolidated Statements Of Operations (USD $)
In Thousands, except Per Share data, unless otherwise specified |
12 Months Ended | 150 Months Ended | |
---|---|---|---|
Dec. 31, 2012
|
Dec. 31, 2011
|
Dec. 31, 2012
|
|
Operating expenses: | |||
Research and development | $ 4,527 | $ 3,552 | $ 27,610 |
General and administrative | 5,372 | 6,857 | 47,036 |
Total operating expenses | 9,899 | 10,409 | 74,646 |
Total operating loss | (9,899) | (10,409) | (74,646) |
Other income (expense): | |||
Interest income | 24 | 18 | 818 |
Interest expense | (4,451) | ||
Change in fair value of convertible debt instrument | (3,426) | ||
Change in fair value of warrant liabilities | (524) | 9,022 | |
Other income | 200 | 691 | |
Total other income (expense) | 224 | (506) | 2,654 |
Net loss | (9,675) | (10,915) | (71,992) |
Preferred stock dividends | (976) | (1,568) | (4,235) |
Preferred stock accretion | (230) | (230) | (4,045) |
Net loss applicable to common stockholders | $ (10,881) | $ (12,713) | $ (80,272) |
Basic and diluted net loss per share | $ (0.72) | $ (1.06) | |
Shares used in computing basic and diluted net loss per share | 15,131 | 11,986 |
X | ||||||||||
- Definition
Change in fair value of warrant No definition available.
|
X | ||||||||||
- Definition
Unrealized Gain (Loss) In Debt Instrument Fair Value No definition available.
|
X | ||||||||||
- Definition
The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. No definition available.
|
X | ||||||||||
- Definition
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The cost of borrowed funds accounted for as interest that was charged against earnings during the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Income derived from investments in debt securities and on cash and cash equivalents the earnings of which reflect the time value of money or transactions in which the payments are for the use or forbearance of money. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Net income after adjustments for dividends on preferred stock (declared in the period) and/or cumulative preferred stock (accumulated for the period). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Definition
Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Definition
The net result for the period of deducting operating expenses from operating revenues. No definition available.
|
X | ||||||||||
- Definition
The aggregate amount of other income amounts, the components of which are not separately disclosed on the income statement, resulting from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business) also known as other nonoperating income recognized for the period. Such amounts may include: (a) dividends, (b) interest on securities, (c) profits on securities (net of losses), and (d) miscellaneous other income items. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The amount of accretion of the preferred stock redemption discount during the period. No definition available.
|
X | ||||||||||
- Definition
The amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders. No definition available.
|
X | ||||||||||
- Definition
The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS). No definition available.
|
Consolidated Statement Of Changes In Redeemable Convertible Preferred Stock And Stockholders' Equity (Deficit) (USD $)
|
Total
USD ($)
|
Issuance During Period 1st
USD ($)
|
Issuance During Period 1st
Notes Payable
USD ($)
|
Issuance During Period 1st
Convertible Notes Payable
USD ($)
|
Issuance During Period 1st
Employee Stock Option
USD ($)
|
Issuance During Period 2nd
USD ($)
|
Issuance During Period 2nd
Convertible Notes Payable
USD ($)
|
Issuance During Period 2nd
Cash
USD ($)
|
Issuance During Period 2nd
Private Placement
USD ($)
|
Issuance During Period 3rd
USD ($)
|
Issuance During Period 3rd
Private Placement
USD ($)
|
Issuance During Period 4th
Notes Payable
USD ($)
|
Issuance During Period 5th
Private Placement
USD ($)
|
Issuance During Period 6th
Consulting Services
USD ($)
|
Issuance During Period 7th
Accrued Liabilities
USD ($)
|
Issuance During Period 8th
Private Placement
USD ($)
|
Issuance During Period 9th
Private Placement
USD ($)
|
Issuance During Period 10th
Private Placement
USD ($)
|
Issuance During Period 11th
Private Placement
USD ($)
|
Issuance During Period 12th
Cash
USD ($)
|
Issuance During Period 14th
USD ($)
|
Series A 12% Convertible Preferred Stock
USD ($)
|
Series A 12% Convertible Preferred Stock
Issuance During Period 1st
Private Placement
USD ($)
|
Series B-1 12% Redeemable Convertible Preferred Stock
|
Series B-1 12% Redeemable Convertible Preferred Stock
Transaction 01
USD ($)
|
Series B-1 12% Redeemable Convertible Preferred Stock
Issuance During Period 2nd
USD ($)
|
Series B-2 12% Redeemable Convertible Preferred Stock
|
Series B-2 12% Redeemable Convertible Preferred Stock
Transaction 02
USD ($)
|
Series B-2 12% Redeemable Convertible Preferred Stock
Transaction 03
USD ($)
|
Series B-2 12% Redeemable Convertible Preferred Stock
Issuance During Period 3rd
USD ($)
|
Series B-2 12% Redeemable Convertible Preferred Stock
Period 1
USD ($)
|
Series C Super Dividend Convertible Preferred Stock
USD ($)
|
Series C Super Dividend Convertible Preferred Stock
Issuance During Period 4th
USD ($)
|
Series B Preferred Stock
USD ($)
|
Consultant
USD ($)
|
Common Stock
USD ($)
|
Common Stock
Issuance During Period 1st
|
Common Stock
Issuance During Period 1st
Notes Payable
|
Common Stock
Issuance During Period 1st
Employee Stock Option
|
Common Stock
Issuance During Period 2nd
USD ($)
|
Common Stock
Issuance During Period 2nd
Cash
|
Common Stock
Issuance During Period 3rd
USD ($)
|
Common Stock
Issuance During Period 3rd
Private Placement
USD ($)
|
Common Stock
Issuance During Period 4th
Notes Payable
|
Common Stock
Issuance During Period 5th
Private Placement
|
Common Stock
Issuance During Period 6th
Consulting Services
|
Common Stock
Issuance During Period 7th
Accrued Liabilities
|
Common Stock
Issuance During Period 8th
Private Placement
USD ($)
|
Common Stock
Issuance During Period 9th
Private Placement
|
Common Stock
Issuance During Period 10th
Private Placement
|
Common Stock
Issuance During Period 11th
Private Placement
USD ($)
|
Common Stock
Issuance During Period 12th
Cash
USD ($)
|
Common Stock
Issuance During Period 14th
USD ($)
|
Common Stock
Series A 12% Convertible Preferred Stock
|
Common Stock
Series B-1 12% Redeemable Convertible Preferred Stock
|
Common Stock
Series B-2 12% Redeemable Convertible Preferred Stock
|
Common Stock
Series C Super Dividend Convertible Preferred Stock
|
Common Stock
Series C Super Dividend Convertible Preferred Stock
Issuance During Period 4th
|
Common Stock
Consultant
|
Additional Paid-In Capital
USD ($)
|
Additional Paid-In Capital
Issuance During Period 1st
USD ($)
|
Additional Paid-In Capital
Issuance During Period 1st
Notes Payable
USD ($)
|
Additional Paid-In Capital
Issuance During Period 1st
Convertible Notes Payable
USD ($)
|
Additional Paid-In Capital
Issuance During Period 1st
Employee Stock Option
USD ($)
|
Additional Paid-In Capital
Issuance During Period 2nd
USD ($)
|
Additional Paid-In Capital
Issuance During Period 2nd
Convertible Notes Payable
USD ($)
|
Additional Paid-In Capital
Issuance During Period 2nd
Cash
USD ($)
|
Additional Paid-In Capital
Issuance During Period 2nd
Private Placement
USD ($)
|
Additional Paid-In Capital
Issuance During Period 3rd
USD ($)
|
Additional Paid-In Capital
Issuance During Period 3rd
Private Placement
USD ($)
|
Additional Paid-In Capital
Issuance During Period 4th
Notes Payable
USD ($)
|
Additional Paid-In Capital
Issuance During Period 5th
Private Placement
USD ($)
|
Additional Paid-In Capital
Issuance During Period 6th
Consulting Services
USD ($)
|
Additional Paid-In Capital
Issuance During Period 7th
Accrued Liabilities
USD ($)
|
Additional Paid-In Capital
Issuance During Period 8th
Private Placement
USD ($)
|
Additional Paid-In Capital
Issuance During Period 9th
Private Placement
USD ($)
|
Additional Paid-In Capital
Issuance During Period 10th
Private Placement
USD ($)
|
Additional Paid-In Capital
Issuance During Period 11th
Private Placement
USD ($)
|
Additional Paid-In Capital
Issuance During Period 12th
Cash
USD ($)
|
Additional Paid-In Capital
Issuance During Period 14th
USD ($)
|
Additional Paid-In Capital
Series A 12% Convertible Preferred Stock
USD ($)
|
Additional Paid-In Capital
Series B-1 12% Redeemable Convertible Preferred Stock
USD ($)
|
Additional Paid-In Capital
Series B-1 12% Redeemable Convertible Preferred Stock
Issuance During Period 2nd
USD ($)
|
Additional Paid-In Capital
Series B-2 12% Redeemable Convertible Preferred Stock
USD ($)
|
Additional Paid-In Capital
Series B-2 12% Redeemable Convertible Preferred Stock
Issuance During Period 3rd
USD ($)
|
Additional Paid-In Capital
Series B-2 12% Redeemable Convertible Preferred Stock
Period 1
USD ($)
|
Additional Paid-In Capital
Series C Super Dividend Convertible Preferred Stock
USD ($)
|
Additional Paid-In Capital
Series C Super Dividend Convertible Preferred Stock
Issuance During Period 4th
USD ($)
|
Additional Paid-In Capital
Consultant
USD ($)
|
Series A 12% Convertible Preferred Stock
USD ($)
|
Series A 12% Convertible Preferred Stock
USD ($)
|
Series A 12% Convertible Preferred Stock
Issuance During Period 1st
Private Placement
USD ($)
|
Deficit Accumulated During the Development Stage
USD ($)
|
Deficit Accumulated During the Development Stage
Series A 12% Convertible Preferred Stock
USD ($)
|
Deficit Accumulated During the Development Stage
Series B-1 12% Redeemable Convertible Preferred Stock
USD ($)
|
Deficit Accumulated During the Development Stage
Series B-1 12% Redeemable Convertible Preferred Stock
Transaction 01
USD ($)
|
Deficit Accumulated During the Development Stage
Series B-2 12% Redeemable Convertible Preferred Stock
USD ($)
|
Deficit Accumulated During the Development Stage
Series B-2 12% Redeemable Convertible Preferred Stock
Transaction 02
USD ($)
|
Deficit Accumulated During the Development Stage
Series B-2 12% Redeemable Convertible Preferred Stock
Transaction 03
USD ($)
|
Deficit Accumulated During the Development Stage
Series C Super Dividend Convertible Preferred Stock
USD ($)
|
Deficit Accumulated During the Development Stage
Series B Preferred Stock
USD ($)
|
Series B-1 12% Redeemable Convertible Preferred Stock
USD ($)
|
Series B-1 12% Redeemable Convertible Preferred Stock
Transaction 01
USD ($)
|
Series B-1 12% Redeemable Convertible Preferred Stock
Issuance During Period 2nd
USD ($)
|
Series B-1 12% Redeemable Convertible Preferred Stock
Series B Preferred Stock
USD ($)
|
Series B-2 12% Redeemable Convertible Preferred Stock
USD ($)
|
Series B-2 12% Redeemable Convertible Preferred Stock
Transaction 02
USD ($)
|
Series B-2 12% Redeemable Convertible Preferred Stock
Transaction 03
USD ($)
|
Series B-2 12% Redeemable Convertible Preferred Stock
Issuance During Period 3rd
USD ($)
|
Series B-2 12% Redeemable Convertible Preferred Stock
Period 1
USD ($)
|
Series B-2 12% Redeemable Convertible Preferred Stock
Series B Preferred Stock
USD ($)
|
Series C Super Dividend Convertible Preferred Stock
USD ($)
|
Series C Super Dividend Convertible Preferred Stock
USD ($)
|
Series C Super Dividend Convertible Preferred Stock
Issuance During Period 4th
USD ($)
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Beginning Balance at Jul. 10, 2000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Issuance of common stock and warrants, net of issuance costs of $1,597,000 in 2012 and $17,000 in 2001 (in shares) | 114,884 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Issuance of common stock and warrants, net of issuance costs of $1,597,000 in 2012 and $17,000 in 2001 | $ 2,221,000 | $ 2,221,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Issuance of shares related to reverse split of common stock | 3,324 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Issuance of restricted common stock | 454,167 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Issuance of restricted common stock | 1,000 | (1,000) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Issuance of common stock upon exercise of warrants | 3,419,570 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Issuance of common stock upon exercise of warrants | 14,307,000 | 3,000 | 14,304,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Issuance of common stock upon exercise of options | 2,772 | 398,937 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Issuance of common stock upon exercise of options | 74,000 | 362,000 | 1,000 | 74,000 | 361,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock-based compensation expense | 11,635,000 | 11,635,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Net loss | (71,992,000) | (71,992,000) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Issuance of founders shares July 10, 2000 (in shares) | 2,059,112 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Issuance of founders shares July 10, 2000 | 9,000 | 2,000 | 7,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Convertible preferred stock dividend (in shares) | 160,330 | 298,807 | 568,721 | 63,119 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Convertible preferred stock dividend | (47,000) | (33,000) | 875,000 | 1,034,000 | 2,022,000 | 224,000 | (922,000) | (1,034,000) | (2,022,000) | (257,000) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Beneficial conversion feature | 222,000 | 1,016,000 | 222,000 | 1,016,000 | (1,016,000) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Issuance of common stock and beneficial conversion feature related to convertible note in 2001 (in shares) | 110,054 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Issuance of common stock and beneficial conversion feature related to convertible note in 2001 | 1,036,000 | 1,036,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Issuance of common stock in connection with reverse merger of Pro-Pharmaceuticals-NV in 2001 (in shares) | 203,649 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Issuance of common stock in connection with reverse merger of Pro-Pharmaceuticals-NV in 2001 | 107,000 | 107,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Issuance of common stock (in shares) | 99,705 | 31,000 | 537,227 | 17,647 | 181,334 | 2,042 | 33,618 | 399,917 | 219,096 | 206,019 | 333,334 | 1,250,000 | 2,666,722 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Issuance of common stock | 1,126,000 | 602,000 | 2,861,000 | 290,000 | 1,070,000 | 12,000 | 302,000 | 4,410,000 | 1,319,000 | 1,898,000 | 490,000 | 1,044,000 | 10,403,000 | 1,000 | 1,000 | 1,000 | 1,000 | 3,000 | 1,126,000 | 602,000 | 2,860,000 | 290,000 | 1,070,000 | 12,000 | 302,000 | 4,409,000 | 1,319,000 | 1,898,000 | 489,000 | 1,043,000 | 10,400,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Issuance of Common Stock Warrants | 503,000 | 236,000 | 261,000 | 20,000 | 503,000 | 236,000 | 261,000 | 20,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Receipt of subscription receivable | 150,000 | 150,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Reclassification of Warrant Liabilities | 3,193,000 | 3,193,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Deferred compensation relating to issuance of stock options | 455,000 | 455,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock compensation expense related to fair market revaluation | 157,000 | 157,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock compensation related to the issuance of common shares (in shares) | 12,515 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock compensation related to the issuance of common shares | 53,000 | 53,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cumulative effect of adoption of new accounting principle | (204,000) | (458,000) | 254,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accretion of redeemable convertible preferred stock | (1,303,000) | (2,057,000) | (685,000) | (1,303,000) | (2,057,000) | (685,000) | 1,303,000 | 2,057,000 | 685,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Issuance of redeemable convertible preferred stock (in shares) | 1,742,500 | 900,000 | 2,100,000 | 225 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Issuance of redeemable convertible preferred stock | 704,000 | 1,105,000 | 2,761,000 | 1,105,000 | 2,761,000 | 704,000 | 395,000 | 1,174,000 | 2,203,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock issued in conversion of convertible securities (in shares) | 79,367 | 1,227,972 | 867,558 | 30,000 | 8,334 | (180,000) | (5) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock issued in conversion of convertible securities | 1,745,000 | 3,948,000 | 5,330,000 | 49,000 | 1,000 | 1,000 | 1,745,000 | 3,947,000 | 5,329,000 | 72,000 | 49,000 | (72,000) | (49,000) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ending Balance at Dec. 31, 2012 | 1,165,000 | 16,000 | 80,535,000 | 632,000 | (80,018,000) | 1,698,000 | 2,154,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ending Balance (in shares) at Dec. 31, 2012 | 16,060,853 | 1,562,500 | 900,000 | 220 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Beginning Balance at Dec. 31, 2009 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Issuance of common stock (in shares) | 770,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ending Balance at Dec. 31, 2010 | (1,694,000) | 11,000 | 54,075,000 | 644,000 | (56,424,000) | 1,664,000 | 2,474,000 | 2,073,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ending Balance (in shares) at Dec. 31, 2010 | 10,651,535 | 1,592,500 | 900,000 | 2,100,000 | 212 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accretion of beneficial conversion feature for Series B-2 | (54,000) | (54,000) | 54,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Issuance of restricted common stock | 20,834 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Issuance of common stock upon exercise of warrants | 1,771,383 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Issuance of common stock upon exercise of warrants | 7,218,000 | 2,000 | 7,216,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Issuance of common stock upon exercise of options | 216,443 | 216,440 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Issuance of common stock upon exercise of options | 234,000 | 234,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock-based compensation expense | 3,245,000 | 3,245,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Net loss | (10,915,000) | (10,915,000) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Convertible preferred stock dividend (in shares) | 30,321 | 59,588 | 139,037 | 17,066 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Convertible preferred stock dividend | 1,000 | (33,000) | 180,000 | 378,000 | 881,000 | 97,000 | (179,000) | (378,000) | (881,000) | (130,000) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Issuance of common stock (in shares) | 13 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Issuance of common stock | 130,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accretion of redeemable convertible preferred stock | (176,000) | (176,000) | 17,000 | 159,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock issued in conversion of convertible securities (in shares) | 5,000 | 8,334 | (30,000) | (5) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock issued in conversion of convertible securities | 49,000 | 12,000 | 49,000 | (12,000) | (49,000) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ending Balance at Dec. 31, 2011 | (2,125,000) | 13,000 | 66,367,000 | 632,000 | (69,137,000) | 1,681,000 | 2,687,000 | 2,154,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ending Balance (in shares) at Dec. 31, 2011 | 12,919,538 | 1,562,500 | 900,000 | 2,100,000 | 220 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accretion of beneficial conversion feature for Series B-2 | (56,000) | (56,000) | 56,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Issuance of common stock and warrants, net of issuance costs of $1,597,000 in 2012 and $17,000 in 2001 (in shares) | 2,666,722 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Issuance of common stock and warrants, net of issuance costs of $1,597,000 in 2012 and $17,000 in 2001 | 10,403,000 | 3,000 | 10,400,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Issuance of shares related to reverse split of common stock | 3,324 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Issuance of common stock upon exercise of warrants | 12,177 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Issuance of common stock upon exercise of options | 51,830 | 51,830 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock-based compensation expense | 2,766,000 | 2,766,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Net loss | (9,675,000) | (9,675,000) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Convertible preferred stock dividend (in shares) | 31,250 | 95,584 | 223,027 | 46,053 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Convertible preferred stock dividend | (123,000) | 103,000 | 224,000 | 522,000 | 127,000 | (103,000) | (224,000) | (522,000) | (127,000) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Issuance of common stock (in shares) | 11,348 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Issuance of common stock | 68,800,000 | 26,000 | 26,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accretion of redeemable convertible preferred stock | (174,000) | (174,000) | 17,000 | 157,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ending Balance at Dec. 31, 2012 | $ 1,165,000 | $ 16,000 | $ 80,535,000 | $ 632,000 | $ (80,018,000) | $ 1,698,000 | $ 2,900,000 | $ 2,154,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ending Balance (in shares) at Dec. 31, 2012 | 16,060,853 | 1,562,500 | 900,000 | 2,100,000 | 220 |
X | ||||||||||
- Definition
Accretion on redeemable convertible preferred stock. No definition available.
|
X | ||||||||||
- Definition
Adjustments To Additional Paid In Capital Deferred Compensation No definition available.
|
X | ||||||||||
- Definition
Cumulative Effect of Initial Adoption of New Accounting Principle, Gross No definition available.
|
X | ||||||||||
- Definition
Issuance Of Common Stock And Warrants, Shares No definition available.
|
X | ||||||||||
- Definition
Value of issuance of common stock and warrants. No definition available.
|
X | ||||||||||
- Definition
Issuance Of Redeemable Preferred Stock, Shares No definition available.
|
X | ||||||||||
- Definition
Issuance Of Redeemable Preferred Stock Value No definition available.
|
X | ||||||||||
- Definition
Reclassification of Warrants to a Liability No definition available.
|
X | ||||||||||
- Definition
Stock-based Compensation Expense. No definition available.
|
X | ||||||||||
- Definition
Stock Issued During Period Shares Conversion Or Exchange Of Convertible Securities No definition available.
|
X | ||||||||||
- Definition
Stock Issued During Period, Shares, Founders No definition available.
|
X | ||||||||||
- Definition
Number of shares of stock issued during the period pursuant to a merger. No definition available.
|
X | ||||||||||
- Definition
Number of shares issued during the period as a result of the exercise of warrants. No definition available.
|
X | ||||||||||
- Definition
Stock Issued During Period Value Conversion Or Exchange Of Convertible Securities No definition available.
|
X | ||||||||||
- Definition
Stock Issued During Period, Value, Founders No definition available.
|
X | ||||||||||
- Definition
Value of stock issued pursuant to a merger during the period. No definition available.
|
X | ||||||||||
- Definition
Value stock issued during the period as a result of the exercise of warrants. No definition available.
|
X | ||||||||||
- Definition
Value Of Beneficial Conversion Feature Of Preferred Stock No definition available.
|
X | ||||||||||
- Definition
This element represents the amount of recognized equity-based compensation during the period, that is, the amount recognized as expense in the income statement (or as asset if compensation is capitalized). Alternate captions include the words "stock-based compensation". Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Increase in additional paid in capital due to warrants issued during the period. Includes also the proceeds of debt securities issued with detachable stock purchase warrants that are allocable to the warrants. These warrants qualify for equity classification and provide the holder with a right to purchase stock from the entity. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Equity impact of aggregate cash, stock, and paid-in-kind dividends declared for preferred shareholders during the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Number of shares of preferred stock issued as dividends during the period. Excludes stock splits. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Number of shares issued and outstanding as of the balance sheet date. No definition available.
|
X | ||||||||||
- Definition
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Number of shares issued during the period as a result of the conversion of convertible securities. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Number of new stock issued during the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Reduction in the number of shares during the period as a result of a reverse stock split. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Number of shares (or other type of equity) issued during the period as a result of any equity-based compensation plan other than an employee stock ownership plan (ESOP), net of any shares forfeited. Shares issued could result from the issuance of restricted stock, the exercise of stock options, stock issued under employee stock purchase plans, and/or other employee benefit plans. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Number of share options (or share units) exercised during the current period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The gross value of stock issued during the period upon the conversion of convertible securities. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Value of stock (or other type of equity) issued during the period as a result of any equity-based compensation plan other than an employee stock ownership plan (ESOP), net of stock value of such awards forfeited. Stock issued could result from the issuance of restricted stock, the exercise of stock options, stock issued under employee stock purchase plans, and/or other employee benefit plans. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Value of stock issued as a result of the exercise of stock options. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Revenue from circulation or sale of subscriptions (for example, but not limited to, subscriptions to a magazine or newspaper). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Value of accretion of temporary equity to its redemption value during the period. This item is an adjustment to net income necessary to derive net income apportioned to common stockholders and is to be distinguished from Temporary Equity, Accretion to Redemption Value (TemporaryEquityAccretionToRedemptionValue). No definition available.
|
Consolidated Statement Of Changes In Redeemable Convertible Preferred Stock And Stockholders' Equity (Deficit) (Parenthetical) (USD $)
|
12 Months Ended | 150 Months Ended |
---|---|---|
Dec. 31, 2012
|
Dec. 31, 2012
|
|
Issuance of stock, issuance costs | $ 1,597,000 | $ 17,000 |
Issuance During Period 14th
|
||
Issuance of stock, issuance costs | 1,597,000 | |
Series B-1 12% Redeemable Convertible Preferred Stock | Issuance During Period 2nd
|
||
Issuance of stock, issuance costs | 300,000 | |
Series B-2 12% Redeemable Convertible Preferred Stock | Issuance During Period 3rd
|
||
Issuance of stock, issuance costs | 188,000 | |
Series C Super Dividend Convertible Preferred Stock | Issuance During Period 4th
|
||
Issuance of stock, issuance costs | 47,000 | |
Cash | Issuance During Period 2nd
|
||
Issuance of stock, issuance costs | 49,000 | |
Cash | Issuance During Period 12th
|
||
Issuance of stock, Date | Feb. 25, 2008 | |
Issuance of stock, issuance costs | 369,000 | |
Private Placement | Issuance During Period 3rd
|
||
Issuance of stock, issuance costs | 212,000 | |
Private Placement | Issuance During Period 5th
|
||
Issuance of stock, issuance costs | 18,000 | |
Private Placement | Issuance During Period 8th
|
||
Issuance of stock, issuance costs | 128,000 | |
Private Placement | Issuance During Period 9th
|
||
Issuance of stock, issuance costs | 559,000 | |
Private Placement | Issuance During Period 10th
|
||
Issuance of stock, issuance costs | 466,000 | |
Private Placement | Issuance During Period 11th
|
||
Issuance of stock, issuance costs | 485,000 | |
Private Placement | Series A 12% Convertible Preferred Stock | Issuance During Period 1st
|
||
Issuance of stock, Date | Feb. 04, 2008 | |
Issuance of stock, issuance costs | $ 52,000 |
X | ||||||||||
- Definition
Stock Issuance Costs No definition available.
|
X | ||||||||||
- Definition
Date of equity securities issuance, in CCYY-MM-DD format. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Cashless Exercise of Stock Options and Warrants No definition available.
|
X | ||||||||||
- Definition
Change in fair value of warrant No definition available.
|
X | ||||||||||
- Definition
Conversion Of Accrued Liabilities To Common Stock No definition available.
|
X | ||||||||||
- Definition
Issuance of equity warrants in connection with equity offerings No definition available.
|
X | ||||||||||
- Definition
Issuance of warrants to induce conversion of notes payable No definition available.
|
X | ||||||||||
- Definition
The cash inflow associated with the amount received from holders exercising their stock options and warrants. No definition available.
|
X | ||||||||||
- Definition
Supplemental Dividends on ESOP convertible preferred stock No definition available.
|
X | ||||||||||
- Definition
Unrealized Gain (Loss) In Debt Instrument Fair Value No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Definition
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X |
- Definition Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. Reference 1: http://www.xbrl.org/2003/role/presentationRef |